knowledge -WSS

knowledge

author：comprehensive 2025-09-30 18:00:37 - browse：199

om DiLenge (CQ in grey suit ) Flagship Pioneering Cambridge with US Congressman Raja Krishnamoorthi of Illinois were talking together at the event. Biotech companies demonstrating their medicines and materials at a "tech fair" designed to showcase the need to compete with Chinese biotech held at Harvard Kennedy School in Cambridge. The growing US backlash against the perceived national security threat posed by China's rising biotech industry — Tom DiLenge of Flagship Pioneering (left) with U.S. Congressman Raja Krishnamoorthi of Illinois at a "tech fair" designed to showcase the need to compete with Chinese biotech held at Harvard Kennedy School in Cambridge, Mass. David L Ryan/The Boston Globe

CAMBRIDGE, Mass. — The increasingly adversarial relationship between the United States and China has raised national security concerns about Chinese penetration into key sectors of the U.S. economy, such as technology, manufacturing, and clean energy.

Now, some in Congress are raising alarms about China’s threat to another vital industry: biotechnology.

A bipartisan group of lawmakers visited Massachusetts this week to call attention to that threat and call for strengthening U.S. life sciences companies, protecting their technologies, and safeguarding Americans’ genetic data from a Chinese biotech industry with close ties to the authoritarian state.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Trump's false claims about Georgia's 2020 election long debunked

entertainment

WSS

In key trial, Verve's treatment lowers cholesterol levels in patients

Patient advocates sound warning on FDA proposal on salt intake

Does good food count as health care? Study aims to find out

FDA's Woodcock to retire early next year

FDA approves first treatment for ultra

Evacuations in place as 3 wildfires burn in eastern Washington state

focus

knowledge

knowledge

DIEP, the 'gold standard' of breast reconstruction, is under threat

Buoyed by wins on obesity, Novo Nordisk eyes heart disease

Medical leaders decry Supreme Court decision on affirmative action

Weight loss drug Wegovy cuts risk of heart attacks in milestone trial

Supreme Court strikes down use of affirmative action

Readout Newsletter: What is Casgevy? Does Wegovy hurt muscle?

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

An interview with Robert F. Kennedy Jr. on vaccines

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Clinical trials must include more disabled people

leisure time

Lung cancer is America's deadliest cancer. Yet so few get screened

NYU radiologists take on the challenge of expensive MRI machines

Buoyed by wins on obesity, Novo Nordisk eyes heart disease

Lung cancer is America's deadliest cancer. Yet so few get screened

Weight loss drug Wegovy cuts risk of heart attacks in milestone trial

FDA approves first treatment for ultra

explore

focus

entertainment

leisure time